GlobeNewswire by notified

CMR Surgical announces more than 100 Versius systems installed globally

Share

CMR Surgical announces more than 100 Versius systems installedglobally

  • CMR isdelivering on its commercial strategy of rapid global expansion with systems installed across the world and more than 5,000 clinical cases performed

CAMBRIDGE, UK 17November2022, 07:00 (GMT). CMR Surgical (CMR) – the global surgical robotics business – today provides an update on progress, as the Company announces it has now installed more than 100 Versius® Surgical Robotic Systems commercially. Versius was first introduced to the market in 2019 to make surgical robotics more widely accessible and affordable worldwide, so more patients can receive the benefits of minimal access surgery.

CMR has continued to scale-up rapidly and has now installed the next-generation robotic system across Europe, Asia, Australia, Latin America, and the Middle East.

Recent installations across Europe include world leading cancer and research centre Institut Curie in France, ASST Santi Paolo e Carlo in Milan and in the UK, NHS Wales acquired four systems as part of a pioneering national surgical robotics programme.

Following regulatory approval in Brazil, CMR has further expanded with a number of new customers in the region with Hospital Moinhos de Vento, Hospital e Maternidade Rede D'Or São Luiz Itaim, Hospital Unimed Litoral, Hospital Baia Sul and BP Beneficencia Portuguesa de São Paulo.

In addition, leading institutions across India including Zen Hospital in Mumbai and GEM Hospital in Coimbatore have become the latest to start using the system as CMR increases access to surgical robotics around the world.

The global surgical robotics market continues to grow rapidly and is currently estimated to be worth $6 billioni. CMR is capitalising on this growth with momentum continuing to build for Versius. CMR’s system is the only small, portable, and modular surgical robot on the market, which is an attractive proposition to customers as they roll out surgical robotics programmes to drive efficiency.

Per Vegard Nerseth, Chief Executive Officer of CMR Surgical, comments: “This is a significant milestone for CMR as we continue to deliver on our ambitious commercial plans. We have seen strong and growing demand for Versius across the world in the last year, as both public health systems and private centres increasingly recognise the value in a small, modular and portable system. A key focus for us is always on finding the right partners, and we are proud to be partnering with world-class hospitals and surgeons, many of which could not previously adopt a surgical robot.”

Evandro Moraes, Chief Administrative Officer, Hospital Moinhos de Vento comments: “It is great to be able to offer our patients robotic assisted surgery thanks to the introduction of an innovative new system, Versius. Due to being small and modular we have been able to adopt the system and offer the benefits of robotic surgery to many more patients.”

CMR is further scaling its operations worldwide to meet the demand for Versius, and work is currently underway to build a major manufacturing facility in Cambridgeshire, spanning over 7000 sq. meters, which will be the Company’s global exports hub. To further support CMR’s expansion strategy and help deliver growth in key markets, the Company plans to open additional European offices in the coming months.

This update follows the recent news that Versius has now been used in more than 5,000 clinical cases, across 128 procedure types in specialties including gynaecology, colorectal surgery, thoracic surgery, general surgery and urology.

— ENDS —

Media Contacts:

If you wish to see more, please contact CMR Surgical at:

Press Office, CMR Surgical
T +44(0) 1223 755801
Epressoffice@cmrsurgical.com

Notes to editors:

The Versius® Surgical Robotic System

Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.

Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.

But it’s more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

About CMR Surgical Limited

CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot.

Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.

Founded in 2014, CMR Surgical is private limited company backed by an international shareholder base.


i Verified Market Research, 2021

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction: AB Linas Agro Group investors calendar for the 20232.12.2022 08:00:43 CET | Press release

A list of key information disclosure dates in 2023: February 28, 2023Interim half-year unaudited report for FY 2022/2023.March 1, 2023Investor Conference Webinar to introduce unaudited financial and activity results for the half-year of FY 2022/2023.May 31, 2023Interim unaudited report for 9 months of FY 2022/2023.June 1, 2023Investor Conference Webinar to introduce unaudited financial and activity results for 9 months of FY 2022/2023.August 31, 2023Interim unaudited report for 12 months of FY 2022/2023.September 4, 2023Investor Conference Webinar to introduce unaudited financial and activity results for 12 months of FY 2022/2023.Week 40 (Oct 2-6, 2023)Notice on Annual General Meeting of shareholders.Week 43 (Oct 23-27, 2023)Resolutions of the Annual General Meeting of shareholders and Annual audited results for FY 2022/2023.November 30, 2023Interim unaudited report for 3 months of 2023/2024 financial year.December 1, 2023Investor Conference Webinar to introduce unaudited financial and

PRESS RELEASE: NACON UNVEILS THE MG-X PRO MADE FOR iPHONE®2.12.2022 08:00:00 CET | Press release

NACON UNVEILS THE MG-X PRO MADE FOR iPHONE® Lesquin, 2 December 2022 – The premium gaming accessories designer NACON is pleased to announce the launch of its new MG-X Pro Made For iPhone® controller. The officially licensed Xbox MG-X Pro Made For iPhone® cloud-gaming controller is the ideal controller for subscribers to Xbox Game Pass Ultimate™. Like the MG-X Pro for Android, which has won critical acclaim since its release in January 2022, the MG-X Pro Made For iPhone® provides all the classic controls of an Xbox controller for cloud gaming on mobile with Game Pass Ultimate™ and with any compatible game in the Apple Store. The MG-X Pro Made for iPhone® is compatible with a wide range of iPhone® models, from the 6S to the latest, thanks to its adjustable holder and Bluetooth® connectivity. The MG-X Pro Made For iPhone® connects to your iPhone® in mere seconds and lets you play all games available in Xbox Game Pass Ultimate™. The ergonomic handles, asymmetric sticks, bumpers, triggers,

KBC Group: KBC Bank Ireland welcomes decision of Minister for Finance to approve the sale of substantially all of its performing loan assets and liabilities to Bank of Ireland Group2.12.2022 08:00:00 CET | Press release

Press Release Outside trading hours – Regulated information* Brussels, 2 December 2022 (8 a.m. CET, before Brussels stock exchange hours) KBC Bank Ireland welcomes decision of Minister for Finance to approve the sale of substantially all of its performing loan assets and liabilities to Bank of Ireland Group. On the 16th of April 2021, KBC Group announced that KBC Bank Ireland had entered into a Memorandum of Understanding (MoU) with Bank of Ireland Group. On the 22nd of October 2021 KBC Bank Ireland entered into a legally binding agreement with Bank of Ireland Group whereby it would acquire substantially all of KBC Bank Ireland’s performing loan assets and deposits. In addition, a small portfolio of non-performing mortgages (NPEs) will also be acquired as part of the transaction. On the 24th of May 2022 the transaction received approval from the Irish Competition and Consumer Protection Commission (CCPC), and today, 2 December 2022, KBC can confirm that the deal received final approval

Mining sector puts energy into ESG, but lacks focus on gender and diversity2.12.2022 08:00:00 CET | Press release

Demand for greater transparency fuels shift in sustainable approach, finds new survey LONDON, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Energy efficiency has soared up the list of environmental priorities for the mining industry and now features in the top three for most companies, along with air and water pollution and waste management. It’s one of the key findings from a survey of global mining sector decision-makers published today by mining executive search and recruitment consultants, Stratum International, and independent ESG accreditors, Digbee. Tackling climate change and biodiversity loss come lower on the list of environmental, social and governance (ESG) factors for many mining businesses, according to the new report. And there’s a concerning lack of focus on gender and diversity for a sector which needs to change the perception that mining is a male-only environment. The issue is deemed the “least important” social priority for mining companies over the next two years. Will Coetzer

Press Release: Statement from Sanofi regarding: rule 2.12 of the takeover rules2.12.2022 07:55:00 CET | Press release

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE "TAKEOVER RULES"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. DECEMBER 2, 2022 Statement from Sanofi regarding: rule 2.12 of the takeover rules Paris, December 2, 2022. As required by Rule 2.12 of the Takeover Rules, Sanofi S.A. (“Sanofi”) confirms that any offer for Horizon Therapeutics plc, if made by Sanofi, will be solely in cash. There is no certainty that any offer will be made, nor as to the terms on which any such offer may be made, if forthcoming. About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible